Snipers Take Aim at the Devil
In what seems like a replay of the sector’s bloodletting circa 1992-93, healthcare stocks are trading down and to the right…
Here is one professionals take...a smart cookie who has made a career out of handicapping hairy situations…
Implications of Democrats coming to power
Timing of potential impact: We believe that any potential healthcare legislation sponsored by the Democrats won’t go into effect until 2010 or later. Congress will likely concentrate on the Iraq war at the onset and any healthcare legislation would likely be vetoed by Bush regardless, therefore we would expect that Democrats wouldn’t attempt any major legislation until there was a Democratic Administration. If a Democratic President took office in 2009, any legislation that was passed that year could only take effect in 2010 or later.
Although any effects from potentially damaging effects from Democratic legislation are far away, the market obviously prices in risk way in advance. The market is likely reacting to the potential for a Democratic President and Democratic Congress in ’08 due to the strength that the Democrats displayed in the midterms.
Furthermore, the market may be extrapolating Hillary Clinton’s landslide win in NY as a strong likelihood that she may be that Democratic President, which would be cause for negative sentiment due to her proposed efforts to introduce price caps for drugs during her husband’s first term. In addition, there is the risk that the Democrats will begin banging the Healthcare drum late next year as candidates ramp up ahead of the Presidential Primaries that kickoff 1Q08.
The risk of negative healthcare legislation is real due to past Democratic efforts. While its not clear at the present time what potential legislation will come about until the Democratic leaders provide more clarity, there are several items that have been discussed in the past
Potential legislative proposals
Drug reimportation legalization:
Negative for: Large Pharma due to lower selling prices in Canada.Distributors would take a hit as well although they have some presence in Canada.
Reimbursement cuts:
Democrats have squeezed healthcare reimbursement in the past through cuts to Medicare and Medicaid (several publicly traded nursing homes went bankrupt during the late 90’s due to changes in the reimbursement codes.) This could potentially be negative for all companies with exposure to Medicare/Medicaid.
Universal Healthcare (insurance for the uninsured):
Positive for: Providers (docs, hospitals, etc), although only to the extent of coverage. This would alleviate some of the bad debt problems of the hospitals although would only be limited in dollar terms. This program wouldn’t likely be a substantial entitlement unless cuts are made elsewhere to pay for it – in which case it may be a zero sum game to providers.
Drug Price caps: This is highly unlikely as this was a debacle in the past. Hopefully this subject does not come into the picture due to its potentially devastating nature.
Direct contracting between the US Govt and Pharma companies: This is another long shot but could offset any of the recent gains from the Medicare Drug Prescription Act for the Pharma companies.
Although we have been hearing that Independent Research is all but dead, the team at Sniper Research LLC have built a thriving business that caters to traders and portfolio managers...you can check them out here…
Editors Note-The First in our new Series...GUEST BLOGGER
Comments:
Next entry: A Thank You to Our Readers
Previous entry: Field of Schemes